CymitQuimica logo

Rapalink-1

CAS:

Ref. 3D-MAD09582

1mg
957.00€
5mg
2,482.00€
10mg
3,970.00€
25mg
7,444.00€
50mg
11,910.00€
Rapalink-1
Biosynth

Product Information

Name:Rapalink-1
Brand:Biosynth
Description:Rapalink-1 is a gene therapy drug that has been shown to be effective against resistant mutants of malignant brain tumors. Rapalink-1 is a protein that has been engineered to bind to mesenchymal markers and inhibit the progression of cancer cells. This protein also has the ability to induce autophagy, which can lead to axonal growth and help with ischemia–reperfusion injury in pediatric patients. Rapalink-1 inhibits tumor growth by triggering autophagy, which can lead to axonal growth and help with ischemia–reperfusion injury in pediatric patients. Rapalink-1 is an autophagy inducer that binds to mesenchymal markers on cancer cells and inhibits the progression of cancer cells. It also has the ability to induce autophagy, which can lead to axonal growth and help with ischemia–reperfusion injury in pediatric patients.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:1,784.1 g/mol
Formula:C91H138N12O24
Purity:Min. 95%

Technical inquiry about: Rapalink-1

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.